Literature DB >> 12625478

Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia.

G J Taborsky1, B Ahren, T O Mundinger, Q Mei, P J Havel.   

Abstract

In summary, this article briefly reviews the evidence that three separate autonomic inputs to the islet are capable of stimulating glucagon secretion and that each is activated during IIH. We have reviewed our evidence that these autonomic inputs mediate the glucagon response to IIH, both in non-diabetic animals and humans. Finally, we outline our new preliminary data suggesting an eSIN in an autoimmune animal model of T1DM. We conclude that the glucagon response to IIH is autonomically mediated in non-diabetic animals and humans. We further suggest that at least one of these autonomic inputs, the sympathetic innervation of the islet, is diminished in autoimmune T1DM. These data raise the novel possibility that an autonomic defect contributes to the loss of the glucagon response to IIH in T1DM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12625478

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  10 in total

1.  Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade.

Authors:  James Leu; Min-Hui Cui; Harry Shamoon; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 2.  Minireview: The value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit.

Authors:  Sue Ritter; Ai-Jun Li; Qing Wang; Thu T Dinh
Journal:  Endocrinology       Date:  2011-08-30       Impact factor: 4.736

3.  Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes.

Authors:  Aris Siafarikas; Robert J Johnston; Max K Bulsara; Peter O'Leary; Timothy W Jones; Elizabeth A Davis
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

4.  Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.

Authors:  Jessica T Y Yue; Elena Burdett; David H Coy; Adria Giacca; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

5.  Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia.

Authors:  Antonia Solomou; Erwann Philippe; Pauline Chabosseau; Stephanie Migrenne-Li; Julien Gaitan; Jochen Lang; Christophe Magnan; Guy A Rutter
Journal:  Nutr Metab (Lond)       Date:  2016-07-07       Impact factor: 4.169

6.  Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats.

Authors:  Rawad Farhat; Eliane de Santana-Van Vliet; Gong Su; Levi Neely; Thea Benally; Owen Chan
Journal:  Endocrinol Diabetes Metab       Date:  2021-02-06

Review 7.  The sympathies of the body: functional organization and neuronal differentiation in the peripheral sympathetic nervous system.

Authors:  Uwe Ernsberger; Thomas Deller; Hermann Rohrer
Journal:  Cell Tissue Res       Date:  2021-11-10       Impact factor: 5.249

Review 8.  Peripheral Innervation in the Regulation of Glucose Homeostasis.

Authors:  Eugene E Lin; Emily Scott-Solomon; Rejji Kuruvilla
Journal:  Trends Neurosci       Date:  2020-11-20       Impact factor: 13.837

9.  Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

10.  Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Sheila Dawling; Stephen N Davis
Journal:  Diabetes       Date:  2008-06-20       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.